# Cannabidiol Medication Intervention Trial

> **NCT06014424** · PHASE2 · RECRUITING · sponsor: **Sunnybrook Health Sciences Centre** · enrollment: 40 (estimated)

## Conditions studied

- Alzheimer Disease

## Interventions

- **DRUG:** CBD
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06014424
- **Lead sponsor:** Sunnybrook Health Sciences Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-09-27
- **Primary completion:** 2026-12-29
- **Final completion:** 2026-12-29
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-01-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06014424

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06014424, "Cannabidiol Medication Intervention Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06014424. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*